Stock listing
08D Stock Price, News, Filings & Events — Mirum Pharmaceuticals, Inc.
Selected listing: 08D · GETTEX · EUR · DE
This page tracks Mirum Pharmaceuticals, Inc.'s 08D:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 08D:GETTEX. 08D:GETTEX is the stock-level entry point for investors researching Mirum Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 08D:GETTEX
- Asset type
- Stock
- Market cap
- $5.96B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Mirum Pharmaceuticals, Inc. 08D:GETTEX stock context
This page tracks Mirum Pharmaceuticals, Inc.'s 08D:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 08D:GETTEX. 08D:GETTEX is the stock-level entry point for investors researching Mirum Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
September 27, 2026
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
September 25, 2026
Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer
September 8, 2026
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
July 29, 2026
Mirum Pharmaceuticals, Inc. earnings calls
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for 08D:GETTEX.
Mirum Pharmaceuticals, Inc. company profile
View the public company page for Mirum Pharmaceuticals, Inc. on 6ix.
Mirum Pharmaceuticals, Inc. news
Read company news and market updates connected to Mirum Pharmaceuticals, Inc..
Mirum Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Mirum Pharmaceuticals, Inc..
Alternate listings
MIRM:NASDAQ
US · USD
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
08D:TRADEGATE
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
A2PM29:LS
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
08D:DUS
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
A2PM29:LSX
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
MIRM:BMV
MX · MXN
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
08D:FWB
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
MIRM:BIVA
MX · MXN
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
MIRM:BOATS
US · USD
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
08D:HAM
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
08D:MUN
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.
08D:SWB
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is 08D:GETTEX.